Long Term Study Leo 90100 on the Body
ClinicalTrials.gov NCT02899962
Research payments
$209,378
Through program year 2019, $209,378 in research payments was reported against Long Term Study Leo 90100 on the Body, across 55 payments, paid by LEO Pharma AS.
- Paid by
- LEO Pharma AS
- ClinicalTrials.gov
- NCT02899962
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $209,378 | 55 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- William Werschler Spokane, WA Named on 10 payments
- Kimberly Grande Knoxville, TN Named on 7 payments
- Terri Nutt San Antonio, TX Named on 4 payments
- Javier Alonso-Llamazares Coral Gables, FL Named on 4 payments
- Linda Stein Gold West Bloomfield, MI Named on 3 payments
- Neil Sadick New York, NY Named on 3 payments
- Stephen Tyring Webster, TX Named on 2 payments
- Leon Kircik Lousiville, KY Named on 2 payments
- John Tu Rochester, NY Named on 2 payments
- Paul Yamauchi Santa Monica, CA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.